Clinical Trial Update: Comparison of the Efficacy of Levofloxacin-based Sequential Therapy and Triple Therapy as Second Line Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing levofloxacin-based sequential therapy versus standard triple therapy for eradication of Helicobacter pylori.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Levofloxacin-based sequential therapy
• Triple therapy

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Eradication Rate for Helicobacter | Phase 4 | Status: UNKNOWN